What Is Salbutamol (Albuterol)? Dosage, Half-Life & How to Track It

What salbutamol is and how it works

Salbutamol (the international name; albuterol is the same drug under its US name) is a short-acting beta-2 adrenergic agonist — the standard rescue bronchodilator for asthma and COPD, sold as an inhaler under brands like Ventolin and ProAir. It relaxes airway smooth muscle within minutes, which is why it is the drug reached for during an asthma flare rather than used as a daily controller medication.

It shares its core mechanism with clenbuterol — both stimulate beta-2 receptors — but salbutamol is shorter-acting and generally regarded as less potent per microgram, which is the pharmacological reason it produces a comparatively lighter, though still genuine, stimulant and cardiovascular effect when used off-label the same way.

The inhaled route (a metered-dose inhaler) is how it is used medically. Oral tablets exist and are the off-label route when it is used for a fat-loss-adjacent effect, since swallowing produces more sustained systemic exposure than the brief, targeted dose of an inhaler puff.

Typical dosing & half-life

Medically, an inhaler delivers a fixed microgram dose per puff (commonly 90–100 mcg), used as needed for symptoms — a fundamentally different exposure pattern than a scheduled oral tablet, since inhaled doses act locally in the airway with only a fraction reaching general circulation.

Off-label oral tablet use produces a much larger systemic dose per unit than an inhaler puff, at the same roughly 4–6 hour half-life — short enough that any effect wears off within a day rather than lingering the way clenbuterol’s longer half-life does.

The inhaler is the FDA-approved, medically intended form. The oral tablet route is the off-label pattern reported for a stimulant/fat-loss effect and carries a meaningfully larger systemic dose than a puff from an inhaler.

How it compares to clenbuterol

Both drugs work on the same beta-2 receptor, and both carry the same class of stimulant side effects — the difference is degree and duration. Salbutamol’s shorter half-life means less accumulation and a shorter comedown, which is part of why some people consider it the "gentler" option, though gentler is relative, not risk-free.

Receptor downregulation with continuous use applies to salbutamol too, the same biology described on the clenbuterol page — which is why off-label oral use tends to follow the same cyclical logic (breaks built in) rather than continuous daily dosing.

What to monitor & the real risks

Tachycardia, tremor (often noticeable in the hands), and a jittery, anxious feeling are the most common effects and scale with dose — the same profile as any beta-2 agonist, just generally milder at typical inhaler-range exposure than at off-label oral tablet doses.

Hypokalemia — low blood potassium — is a real and sometimes underappreciated risk with beta-2 agonists, since receptor stimulation drives potassium from the blood into cells; it matters more at oral tablet doses than at inhaler doses, and more with repeated daily use than an occasional puff. Resting heart rate and how you are sleeping are the simplest daily signals; a basic metabolic panel checking potassium is worth having on file if using it beyond occasional inhaler use for actual respiratory symptoms.

Frequently asked questions